Spyre Therapeutics Inc <SYRE.O>: Wedbush Raises Target Price to $130 From $100
SYRE•Related News
Aurora Cannabis Announces Fiscal 2027 First Quarter Results
ACB•
Zillow Group, Inc. <ZG.O>: Bernstein Cuts Target Price to $50 From $70
ZG•
Flutter Board Announces CEO Transition
FLUT•
BMO Financial Group updates financial calendar with upcoming Q3 2026 results release and investor call
BMO•
Kraft Heinz Declares Qtrly Dividend Of $0.40 Per Share Payable Sept 25, 2026
KHC•